Selgantolimod
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Selgantolimod, covering 2020-04-01 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: Study of Oral TLR8 Agonist Selgantolimod on HBsAg in Participants With Both Chronic Hepatitis B and HIV [Phase 2]